UNCLASSIFIED//
ROUTINE
R 251655Z JUN 20 MID510001339613U
FM CNO WASHINGTON DC
TO NAVADMIN
INFO SECNAV WASHINGTON DC
CNO WASHINGTON DC
BT
UNCLAS
NAVADMIN 178/20
PASS TO OFFICE CODES:
INFO SECNAV WASHINGTON DC//CNO//
MSGID/NAVADMIN/CNO WASHINGTON DC/CNO/JUN//
SUBJ/COVID-19 TESTING//
REF/A/MEMO/OSD/18MAY20//
REF/B/MSG/172057ZZJUN20//
REF/C/MEMO/OSD/11JUN20//
REF/D/MEMO/OSD/11JUN20//
REF/E/MSG/201856ZMAY20//
NARR/REF A IS DOD COVID-19 TASK FORCE MEMORANDUM, TESTING AND REPORTING OF
DOD COVID-19 SCREENING.
REF B IS NAVADMIN 173/20, U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL
GUIDANCE VERSION 2.
REF C IS USD P&R FORCE HEALTH PROTECTION GUIDANCE SUPP 10, DOD GUIDANCE FOR
COVID-19 CLINICAL LABORATORY DIAGNOSTIC TESTING SERVICES.
REF D IS USD P&R FORCE HEALTH PROTECTION GUIDANCE SUPP 11, DOD GUIDANCE FOR
COVID-19 SURVEILLANCE SCREENING AND TESTING.
REF E IS NAVADMIN 147/20, GUIDANCE TO COMMANDERS ON ADJUSTING HEALTH
PROTECTION CONDITIONS AND BASE SERVICES.// POC/RADM KARL THOMAS/OPNAV
N3N5B/703-692-9291/karl.o.thomas1@navy.mil//
RMKS/1. THIS NAVADMIN PROMULGATES NAVYS SENTINEL SURVEILLANCE TESTING (SST)
STRATEGY FOR COVID-19. IT FORMALIZES THE PROCESS TO REQUEST DOD TESTING
CAPACITY FOR NAVY FORCES AND THE REQUIREMENT TO REPORT THE USE OF THOSE
REQUESTED TESTS PER REF A. THIS NAVADMIN SHOULD BE USED IN CONJUNCTION WITH
REF B (COVID-19 STANDARDIZED OPERATIONAL GUIDANCE (SOG) VERSION 2.0), AS
TOGETHER THEY SUPPORT REF C AND NAVYS DIAGNOSTIC TESTING APPROACH. IT
FORMALIZES SURVEILLANCE TESTING AS DIRECTED IN REF D, AND PROVIDES
SUPPLEMENTAL GUIDANCE TO REF E, PARAGRAPH 4.C.4. TESTING FOR COVID-19 HAS
THREE PRIMARY BENEFITS: (1) TESTING CAN UNCOVER ASYMPTOMATIC COVID-POSITIVE
INDIVIDUALS WHO COULD UNWITTINGLY SPREAD THE VIRUS, (2) TESTING CAN ASSIST IN
BOUNDING AN OUTBREAK, AND (3) SURVEILLANCE TESTING CAN BE USED TO DETECT
DISEASE EARLY (A SECOND WAVE OR RESURGENCE).
TESTING ALSO REINFORCES PUBLIC HEALTH MITIGATION MEASURES AND INFORMS OUR
UNDERSTANDING OF COVID-19 TRANSMISSION.
2. REF B, U.S. NAVY COVID-19 STANDARDIZED OPERATIONAL GUIDANCE (SOG) VERSION
2.0, PROVIDES GUIDANCE FOR DEPLOYING FORCES THROUGHOUT THE OPTIMIZED FLEET
RESPONSE PLAN (OFRP). THE GOAL IS TO MINIMIZE THE TRANSMISSION OF COVID-19
ACROSS THE FORCE AND ULTIMATELY CREATE A COVID FREE BUBBLE AROUND UNITS PRIOR
TO AND WHILE DEPLOYED. REF B AND MANY OF OUR PREVENTATIVE EFFORTS HAVE BEEN
FOCUSED ON COVID-FREE DEPLOYABLE UNITS. WE NOW HAVE SUFFICIENT TESTING
CAPACITY TO EXPAND OUR EFFORTS MORE BROADLY ACROSS OUR NAVY. THIS EXPANDED
EFFORT TO PROTECT OUR FORCE INVOLVES TESTING ASYMPTOMATIC POPULATIONS TO
DETECT DISEASE EARLY AND FOCUS PUBLIC HEALTH ACTIONS. THIS IS TERMED
SENTINEL SURVEILLANCE TESTING (SST).
3. SST IS DESIGNED TO BREAK THE CHAIN OF DISEASE TRANSMISSION. IN ADDITION
TO THE ROM-SEQUESTER TESTING FOR DEPLOYING OPERATIONAL FORCES AND ACCESSIONS,
OUR NAVY WILL EXPAND TESTING INTO OTHER ASYMPTOMATIC POPULATIONS WITH A FOCUS
ON THOSE WHO HAVE A HIGHER LIKELIHOOD OF INFECTION.
3.A. REF D DIRECTS DOD COMPONENTS TO TEST: (1) 10 PERCENT OF CLINICAL HEALTH
CARE PERSONNEL EVERY 14 DAYS (20 PERCENT PER MONTH); (2) 10 PERCENT OF
SELECTED POPULATIONS LIVING IN CLOSE SETTINGS EVERY 14 DAYS (20 PERCENT PER
MONTH) AND
(3) AS TESTING RESOURCES INCREASE 1 PERCENT, OF INSTALLATION/UNIT POPULATIONS
EVERY 14 DAYS.
3.B. NAVY WILL PHASE INTO THE ABOVE PERCENTAGES AS TESTING CAPACITY BECOMES
AVAILABLE AND OUR PROCESSES ARE REFINED. WE WILL START BY FOCUSING ON
POPULATIONS WITH HIGHER RISK FOR INFECTION AND TRANSMISSION.
3.C. FDA EMERGENCY USE AUTHORIZATION FOR REVERSE TRANSCRIPTION-POLYMERASE
CHAIN REACTION TESTING IS AUTHORIZED FOR USE IN EXECUTION OF SST.
4. SST CONCEPT OF OPERATIONS.
4.A. TESTING POPULATIONS. NAVY WILL TEST:
4.A.1. THOSE POPULATIONS WITH AN INCREASED RISK OF INFECTION AND SUBSEQUENT
TRANSMISSION TO INCLUDE HEALTH CARE WORKERS, TEAMS WHO FREQUENTLY VISIT A
VARIETY OF COMMANDS (E.G. ATG, NPEB, DGSIT ETC.), SECURITY FORCE PERSONNEL AT
ENTRY CONTROL POINTS, CDC WORKERS, GALLEY EMPLOYEES, BRIGS (STAFF AND
PERSONNEL) ETC.
4.A.2. LEARNING CENTERS AND SCHOOL HOUSES (INSTRUCTORS AND STUDENTS), NAVSEA
FLEET ACTIVITIES AND AVIATION FLEET READINESS CENTERS.
4.A.3. OPERATIONAL UNIT POPULATIONS DURING MAINTENANCE, BASIC AND
SUSTAINMENT PHASES OF OFRP.
4.A.4. HIGH DENSITY OFFICE PERSONNEL (E.G. OPNAV STAFF, FLEET HQS, TYCOM HQ,
NAVSEA AND NAVAIR).
4.B. CONDUCT OF TESTING. THE TESTING SHOULD BE CONDUCTED AND REPORTED IN 14
DAY INCREMENTS. IDEALLY, TESTING WILL BE SPREAD ACROSS THE REPORTING PERIOD
AND GEOGRAPHICALLY DIVERSE TO GIVE THE WIDEST OPPORTUNITY TO SENSE TRENDS.
IF LOGISTICS DICTATE, THE POPULATION BEING TESTED MAY ALL BE TESTED IN ONE
DAY, SPLIT UNIFORMLY ACROSS THE 14 DAYS, OR ANY VARIATION AS LONG AS THE
TARGET SURVEILLANCE NUMBER IS ATTAINED AND RESULTS REPORTED EVERY 14 DAYS.
4.C. PHASED APPROACH TO DOD GOAL. TO REFINE THE EXECUTION OF THIS EFFORT,
NAVY WILL PHASE-IN THE EXECUTION TO ALLOW COLLECTING AND PROMULGATING LESSONS
LEARNED.
5. SST EXECUTION.
5.A. SST PHASE 1. 25 JUNE - 23 JULY; REPORTS DUE 9 JULY AND 23 JULY (14 DAY
INTERVALS). OBJECTIVE IS 900 TESTS ACROSS THE NAVY ENTERPRISE EVERY TWO
WEEKS.
5.A.1. OPNAV WILL TEST 20 PERSONNEL WITHIN N3N5.
5.A.2. BUMED WILL TEST 150 CLINICAL HEALTHCARE WORKERS AT 3 MTFS WITHIN EACH
MEDFOR REGION.
5.A.3. CNIC WILL TEST 100 SECURITY FORCE PERSONNEL ACROSS 2 CNIC REGIONS.
5.A.4. CPF AND FFC WILL EACH TEST 190 PERSONNEL FROM AT LEAST 6 SHIPS/SUBS/
AVIATION SQUADRONS/CSU POOLS WHO ARE IN THE MAINTENANCE, BASIC OR SUSTAINMENT
PHASE OF OFRP AND 1 TEAM DESCRIBED IN PARA 4.A.1.
5.A.5. THE CHIEF OF NAVAL PERSONNEL (CNP) WILL TEST 200 PERSONNEL FROM
STAFF/INSTRUCTORS AT SCHOOLHOUSESAND LEARNING CENTERS IN FLEET CONCENTRATION
AREAS AND BRIGS (STAFF AND PRISONERS).
5.A.6. NAVSEA WILL CONDUCT 30 TESTS AT NAVSEA FIELD ACTIVITIES/HQ STAFFS AND
NAVAIR WILL CONDUCT 20 TESTS AT FLEET READINESS CENTERS (FRC)/HQ STAFFS.
5.B. SST PHASE 2. 23 JULY - 6 AUGUST; REPORTS DUE 6 AUGUST (SINGLE 14 DAY
INTERVAL). OBJECTIVE IS 1720 TESTS ACROSS THE NAVY ENTERPRISE.
5.B.1. OPNAV WILL TEST 50 PERSONNEL WITHIN N2N6, N4, AND N9.
5.B.2. BUMED WILL TEST 700 CLINICAL HEALTHCARE WORKERS ACROSS ALL MTFS.
5.B.3. CNIC WILL TEST 100 SECURITY FORCE PERSONNEL ACROSS 2 CNIC REGIONS.
5.B.4. CPF AND FFC WILL EACH TEST 20 PERSONNEL FROM 1 TEAM DESCRIBED IN PARA
4.A.1 AND 30 PERSONNEL WITHIN HQ STAFFS.
5.B.5. CNP WILL TEST 320 PERSONNEL FROM WITHIN STAFF/INSTRUCTORS AT
SCHOOLHOUSES AND LEARNING CENTERS IN FLEET CONCENTRATION AREAS, HIGH
INTENSITY COURSES, AND BRIGS (STAFF AND PRISONERS).
5.B.6. NAVCENT AND NAVEUR WILL EACH TEST 10 PERSONNEL WITHIN HQ STAFFS AND
160 PERSONNEL TOTAL FROM IN-PORT OPERATIONAL UNITS.
5.B.7. NAVSEA WILL CONDUCT 180 TESTS AT NAVSEA FIELD ACTIVITIES/HQ STAFFS
AND NAVAIR WILL CONDUCT 120 TESTS AT FRCS/HQ STAFFS.
5.C. SST PHASE 3 (FULL IMPLEMENTATION). COMMENCES 6 AUGUST. REPORTS DUE
EVERY
14 DAYS UNTIL TERMINATED. OBJECTIVE IS 3000 TESTS ACROSS NAVY ENTERPRISE
EVERY TWO WEEKS.
5.C.1. OPNAV WILL TEST 20 PERSONNEL WITHIN 1 DIRECTORATE.
5.C.2. BUMED WILL TEST 700 CLINICAL HEALTHCARE WORKERS ACROSS ALL MTFS.
5.C.3. CNIC WILL TEST 300 SECURITY FORCE PERSONNEL ACROSS ALL CNIC REGIONS
AND TEST 100 MISSION CRITICAL OR HIGH RISK PERSONNEL ACROSS ALL REGIONS.
5.C.4. CPF AND FFC WILL EACH TEST 250-300 PERSONNEL FROM AT LEAST
10 SHIPS/SUBS/AVIATION SQUADRONS/CSU POOLS WHO ARE IN THE MAINTENANCE, BASIC
OR SUSTAINMENT PHASE OF OFRP AND 30-80 PERSONNEL FROM THE POPULATIONS
DESCRIBED IN PARA 4.A.1 AND 4.A.4.
5.C.5. CNP WILL TEST 500 PERSONNEL FROM WITHIN STAFF/INSTRUCTORS AT
SCHOOLHOUSES AND LEARNING CENTERS IN FLEET CONCENTRATION AREAS, HIGH
INTENSITY COURSES, BRIGS (STAFF AND PRISONERS) AND RECRUITING PERSONNEL.
5.C.6. NAVCENT AND NAVEUR WILL EACH TEST 20 PERSONNEL WITHIN HQ STAFFS AND
160 PERSONNEL FROM IN-PORT OPERATIONAL UNITS.
5.C.7. NAVSEA WILL CONDUCT 300 TESTS AT NAVSEA FIELD ACTIVITIES/HQ STAFFS
AND NAVAIR WILL CONDUCT 220 TESTS AT FRCS/HQ STAFFS.
6. SPECIAL CONSIDERATIONS.
6.A. TESTING CAPACITY. ALTHOUGH AVAILABLE AT THE DOD LEVEL, NAVY
ACKNOWLEDGES CAPABILITY AND CAPACITY FOR SURVEILLANCE TESTING AND MONITORING
PROGRAMS VARIES AMONG INSTALLATIONS AND UNITS DUE TO CURRENT LIMITATIONS ON
EQUIPMENT, SUPPLIES, AND PERSONNEL RESOURCES. TEST CAPACITY SHOULD BE
PRIORITIZED FOR TIER 0 SITUATIONS (CLINICAL CARE AND OUTBREAK RESPONSE).
6.A.1. LOGISTICS AND TRANSPORT. FOR REMOTE, DEPLOYED, OR UNDERWAY UNITS
WITHOUT INTRINSIC TESTING CAPABILITIES BUT WITH THE ABILITY TO COLLECT
SAMPLES, SURVEILLENCE TESTING PERIODICITY MAY BE ADJUSTED TO REFLECT THE
TIMING AND AVAILABILITY OF COLD-CHAIN TRANSPORT OF SAMPLES TO THE TESTING
FACILITIES.
6.B. INDIVIDUALS WHO WERE PREVIOUSLY COVID-POSITIVE. VIROLOGY TESTING HAS
DEMONSTRATED AN INDIVIDUAL PREVIOUSLY INFECTED WITH COVID-19 WITHIN THE PAST
EIGHT WEEKS MAY TEST POSITIVE FOR COVID-19 EVEN AFTER THE VIRUS IS DEAD (NON-
CONTAGIOUS). THESE INDIVIDUALS SHOULD NOT BE TESTED WITHIN THIS TWO MONTH
PERIOD GIVEN THE POTENTIAL FOR A FALSE POSITIVE TEST.
6.C. ELIGIBILITY FOR TESTING. PER REF C, SERVICE MEMBERS MAY BE TESTED WHEN
IN A TITLE 10 OR TITLE 32 DUTY STATUS. CIVILIAN EMPLOYEES MAY BE OFFERED
TESTING IF THEIR SUPERVISOR DETERMINES THEIR PRESENCE IS URGENTLY REQUIRED
WITHIN THEIR WORKPLACE. FAMILY MEMBERS ELIGIBLE FOR MILITARY HEALTH SYSTEM
BENEFITS MAY BE OFFERED TESTING. EMPLOYEES OF DOD CONTRACTORS WILL USE THE
PROCESSES FOR MEDICAL CARE TO ACCESS TESTING AS SET FORTH IN THE TERMS OF THE
CONTRACT UNDER WHICH THEY ARE PERFORMING. NAVY CIVILIAN EMPLOYEES AND
FAMILIES OF UNIFORMED MEMBERS WILL NOT BE REQUIRED TO SUBMIT TO A COVID-19
SURVEILLANCE TEST IF THEY DO NOT DESIRE TO PARTICIPATE. HOWEVER, VOLUNTEERS
ARE ENCOURAGED AND WELCOME TO DO SO.
6.D. COMMANDERS ARE ENCOURAGED TO SELECT TESTING POPULATIONS THAT BEST
BENEFIT THEIR THREAT AWARENESS, COHORT PROTECTION, AND SST NEEDS. AMONGST
THE CHOSEN POPULATIONS, SPECIFIC INDIVIDUALS SHOULD BE SELECTED AT RANDOM. IF
AN INDIVIDUAL IS RANDOMLY SELECTED MORE THAN ONCE, COMMANDERS MAY PICK
ALTERNATIVES OR SUBSTITUTES TO REPLACE THESE INDIVIDUALS.
6.E. PER REF C, ENSURE APPROPRIATE INFECTION PREVENTION AND CONTROL
PROCEDURES ARE FOLLOWED THROUGHOUT THE ENTIRE TESTING PROCESS. THIS INCLUDES
EMPLOYING THE APPROPRIATE BIOSAFETY PRECAUTIONS WHEN COLLECTING, HANDLING AND
TRANSPORTING SPECIMENS, CONSISTENT WITH CDC GUIDANCE.
6.F. PER REF D, SERVICE MEMBERS WHO ARE TESTED WILL RECEIVE THEIR TEST
RESULTS. COVID-19 POSITIVE TEST RESULTS WILL BE REPORTED IN ACCORDANCE WITH
ALL APPLICABLE FEDERAL, STATE, LOCAL AND DOD REQUIREMENTS AND RECORDED IN
MEMBERS ELECTRONIC HEALTH RECORD.
6.G. OPERATIONAL UNITS THAT HAVE DEVELOPED A COVID-FREE BUBBLE NEED NOT
CONDUCT SURVEILLANCE TESTING AS LONG AS BUBBLE-TO-BUBBLE TRANSFERS AND
RIGOROUS PREVENTATIVE PUBLIC HEALTH MITIGATION MEASURES HAVE BEEN
IMPLEMENTED.
7. HPCON AND TESTING. BROAD IMPLEMENTATION OF ASYMPTOMATIC SURVEILLANCE
TESTINGIS NOT REQUIRED TO BEGIN LOWERING HPCON LEVELS PER REF E, PARAGRAPH
4.C.4. AS TESTING CAPACITY INCREASES, A ROBUST SST AND MONITORING PROGRAM
WILL CONTRIBUTE OBJECTIVE DATA ON COVID-19 PREVALENCE AND ASSISTS IN
PRESERVING FORCE READINESS AND ASSESSING HPCON LEVELS. NAVAL COMPONENT
COMMANDERS (NCCS) REMAIN RESPONSIBLE FOR DETERMINING APPROPRIATE HPCON LEVELS
AND MEASURES GIVEN THE LOCAL OPERATING AND HEALTHCARE THREAT ENVIRONMENT.
VIGILANT ACTIVE AND PASSIVE SURVEILLANCE OF INFLUENZA-LIKE ILLNESS AND
COVID-19-LIKE ILLNESS IS SUFFICIENT UNTIL RESOURCES AND ADDITIONAL DATA
PERMIT IMPLEMENTATION OF WIDESPREAD SST AND MONITORING PROGRAMS.
8. DEPLOYED DIAGNOSTIC TESTING. NAVY HAS DEPLOYED BIOFIRE TESTING
CAPABILITY ONBOARD CVNS/LHAS/LHDS/SSBNS AND SOME LPDS. THESE MACHINES SHOULD
BE USED FOR DIAGNOSTIC TESTING OF SYMPTOMATIC INDIVIDUALS.
9. RAPID RESPONSE FLY-AWAY TEAMS. NAVY HAS POSITIONED ABBOTT ID NOW RAPID
TESTING MACHINES WITH NAVY ENVIRONMENTAL AND PREVENTIVE MEDICINE UNITS AND/OR
PUBLIC HEALTH MEDICAL READINESS RESPONSE TEAMS AT SELECTED LOCATIONS AROUND
THE GLOBE. SHOULD AN OPERATIONAL SHIP OR SUBMARINE HAVE AN OUTBREAK THAT
REQUIRES EXTERNAL ASSISTANCE, NCCS HAVE THE AUTHORITY TO UTILIZE THESE
MACHINES WITH LOCAL MEDICAL TEAMS TO EXECUTE A RAPID RESPONSE.
10. REQUESTING TESTING AND REPORTING REQUIREMENTS.
10.A.1. TIER 1-3 FORCES. PROCESSES ARE IN PLACE FOR NCCS TO REQUEST DOD
TESTING CAPACITY THROUGH THE CNO BWC TO THE JCS COVID TESTING CELL PER REF A.
REQUESTS FOR OPERATIONAL TESTING ACROSS THE NEXT60 DAYS WILL BE PROVIDED TO
THE CNO BWC EACH FRIDAY, WHERE THEY WILL BE AGGREGATED AND SUBMITTED TO THE
DOD COVID-19 TASK FORCE TESTING LINE OF EFFORT (CVTF-D&T). SIMILARLY, TESTS
ACCOMPLISHED THE PRIOR WEEK WILL ALSO BE SUBMITTED TO THE CNO BWC FOR
AGGREGATION AND FORWARDING TO CVTF-D&T. TESTS THAT ARE REQUESTED SHOULD BE
UTILIZED TO ASSIST IN BALANCING TEST DISTRIBUTION AND EFFICIENT USE OF
LIMITED ASSETS. THIS BECOMES EVEN MORE IMPORTANT WITH THE IMPLEMENTATION OF
SST.
10.A.2. SST REPORTING DEADLINES. NCCS, BUMED, N1, AND CNIC WILL PROVIDE SST
REQUIREMENTS AND TESTING COMPLETED EVERY THURSDAY NLT 1400 EST TO CNO BWC FOR
CONSOLIDATION WITH TIER 1-3 INPUTS.
11. MEDICAL TESTING QUESTIONS: BUMED WATCH 703-681-1087/1125 OR NIPR EMAIL:
usn.ncr.bumedfchva.list.bumed---2019-ncov-response-cell@mail.mil. TEST
REQUEST OR REPORTING QUESTIONS: OPNAV BATTLE WATCH CAPTAIN AT 703-692-9284,
DSN 222-9284 OR bwc.ptgn@navy.mil. SURVEILLANCE TESTING FEEDBACK:
RADM KARL THOMAS, karl.o.thomas1@navy.mil OR CAPT RON STOWE,
ronald.stowe@navy.mil.
12. RELEASED BY VADM P. G. SAWYER, DEPUTY CHIEF OF NAVAL OPERATIONS FOR
OPERATIONS, PLANS AND STRATEGY N3/N5//
BT
#0001
NNNN
UNCLASSIFIED//